Veterinary Medicines

Versifel CVR -Wirus panleukopenii kotów (FPV) nie mniej niż 10^3,0 TCID50 i nie więcej niż 10^5,2 TCID50-Herpeswirus kotów typu 1(FVR) nie mniej niż 10^5,0 TCID50 i nie więcej niż 10^7,3 TCID50-Kaliciwirus kotów (FCV) nie mniej niż 10^5,5 TCID50 i nie więcej niż 10^7,5 TCID50 Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań

Authorised
  • Feline panleucopenia virus, Live
  • Felid herpesvirus 1, Live
  • Feline calicivirus, Live
Download as PDF

Product identification

Medicine name:
Versifel CVR -Wirus panleukopenii kotów (FPV) nie mniej niż 10^3,0 TCID50 i nie więcej niż 10^5,2 TCID50-Herpeswirus kotów typu 1(FVR) nie mniej niż 10^5,0 TCID50 i nie więcej niż 10^7,3 TCID50-Kaliciwirus kotów (FCV) nie mniej niż 10^5,5 TCID50 i nie więcej niż 10^7,5 TCID50 Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Active substance:
  • Feline panleucopenia virus, Live
  • Felid herpesvirus 1, Live
  • Feline calicivirus, Live
Target species:
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, Live
    158489.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Felid herpesvirus 1, Live
    19952600.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Feline calicivirus, Live
    31622800.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1962
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download